Long-term MDMA use has long been connected to a form of neurotoxicity that alters and impairs serotonin function during the brain.MAPS is not really supporting off-label use for MDMA therapy right this moment. Now, MDMA therapy is being promoted and tested to be a treatment for PTSD only. MAPS is in the entire process of studying other indications.